IP Library Granted Patent US 10,179,774
Granted Patent B2
US 10,179,774 · App. 15/369,230 · Granted Jan 15, 2019

Synthesis of chirally purified substituted benzothiazole diamines

Inventors: Prasad Raje (North Syracuse, NY); Rajendrakumar Reddy Gadikota (North Syracuse, NY); Jian-Xie Chen (Manlius, NY); Olga V. Lapina (Clifton Park, NY); John M. McCall (Boca Grande, FL)
Assignee: Knopp Biosciences LLC
C07D277/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,774
App. No.
15/369,230
Granted
Jan 15, 2019
Kind
B2
Abstract

Methods for preparing chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamines such as, for example, (6R)2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole and purifying a dominant enantiomer of substituted 4,5,6,7-tetrahydro-benzothiazole diamines from entantiomerically enriched mixtures of substituted 4,5,6,7-tetrahydro-benzothiazole diamines are provided herein.

Claims (52)

1. A process for preparing a chirally purified substituted 4,5,6,7,-tetrahydro-benzothaizole diamine dihydrochloride comprising:

a. heating a solution to a temperature of from about 65° C. to about 125° C., the solution comprising enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine of formula (1):

wherein:

R 1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl or alkynyl group having 3 to 6 carbon atoms, an alkanoyl group having 1 to 6 carbon atoms, a phenyl alkyl or phenyl alkanoyl group having 1 to 3 carbon atoms in the alkyl part;

R 2 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms;

R 3 is a hydrogen atom, an alkyl group having 1 to 7 carbon atoms, a cycloalkyl group having 3 to 7 carbon atoms, an alkenyl or alkynyl group having 3 to 6 carbon atoms, an alkanoyl group having 2 to 7 carbon atoms, a phenyl alkyl or phenyl alkanoyl group having 1 to 3 carbon atoms in the alkyl part;

R 4 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkenyl or alkynyl group having 3 to 6 carbon atoms; and

at least one or R 1 , R 2 , R 3 or R 4 is a hydrogen in an organic solvent; and

a propyl sulfonate or a propyl halide in a solvent to form a reaction mixture;

b. reacting the reaction mixture at a temperature of from about 65° C. to about 125° C.;

c. recovering a chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine or salt thereof and

d. converting the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine to the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine dichloride salt.

2. The process of claim 1 , wherein the steps of heating in step a., and reacting in step b., are carried out from about 65° C. to about 100° C.

3. The process of claim 1 , wherein the steps of heating in step a., and reacting in step b., are carried out from about 65° C. to about 95° C.

4. The process of claim 1 , wherein the propyl halide selected from an n-propyl bromide, n-propyl chloride, n-propyl iodide, and combinations thereof.

5. The process of claim 4 , wherein the propyl chloride is n-propyl chloride.

6. The process of claim 1 , wherein the propyl sulfonate is n-propyl tosylate.

7. The process of claim 1 , wherein the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is at least greater than about 90% chirally pure.

8. The process of claim 1 , wherein the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is at least greater than about 99% chirally pure.

9. The process of claim 1 , wherein the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is at least about 99.9% chirally pure.

10. The process of claim 1 , wherein the chemical purity of the substituted 4,5,6,7-tetrahydro-benzothiazole diamine is greater than about 98%.

11. The process of claim 1 , wherein the chemical purity of the substituted 4,5,6,7-tetrahydro-benzothiazole diamine is greater than about 99%.

12. The process of claim 1 , wherein the chemical purity of the substituted 4,5,6,7-tetrahydro-benzothiazole diamine is 97%.

13. The process of claim 1 , wherein the enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine is enantiomerically enriched for an R-enantiomer and chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is chirally purified for an R-enantiomer.

14. The process of claim 1 , wherein the enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine is enantiomerically enriched for (6R)-2,6 diamino-4,5,6,7-tetrahydro-benzothiazole and the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine.

15. The process of claim 1 , wherein the enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine is enantiomerically enriched for an S-enantiomer and the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is chirally purified for an S-enantiomer.

16. The process of claim 1 , wherein the enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine is enantiomerically enriched for (6S)-2,6 diamino-4,5,6,7-tetrahydro-benzothiazole and the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine is (6S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine.

17. The process of claim 1 , wherein the enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine comprises a ratio of greater than about 1:4 R-enantiomer to S-enantiomer to about 4:1 R-enantiomer to S-enantiomer.

18. The process of claim 1 , wherein the solvent is selected from an organic solvent and an organic solvent mixed with water.

19. The process of claim 1 , wherein steps a., b., and each further comprise stirring.

20. The process of claim 1 , wherein step c. comprises one or more steps selected from filtering the reaction mixture to isolate a precipitate, washing a precipitate, and drying a precipitate.

21. The process of claim 1 , wherein the solution of step a. comprises enantiomerically enriched 4,5,6,7-tetrahydro-benzothiazole diamine of formula (1) and a propyl halide and the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine of step c. is a chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine monohydrochloride salt.

22. The process of claim 1 , wherein the solution of step a. comprises enantiomerically enriched4,5,6,7-tetrahydro-benzothiazole diamine of formula (1) and a propyl sulfonate and the chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine of step c. is a chirally purified substituted 4,5,6,7-tetrahydro-benzothiazole diamine sulfonic acid salt.

23. The process of claim 1 , wherein step d comprises i) dissolving the 4,5,6,7-tetrahydro-benzothiazole diamine or salt thereof of step c. in a solvent; ii) adding hydrochloric acid and iii) isolating the 4,5,6,7,-tetrahydro-benzothaizole diamine dihydrochloride.

24. The process of claim 23 wherein the 4,5,6,7-tetrahydro-benzothiazole diamine or salt thereof of step c. is the 4,5,6,7-tetrahydro-benzothiazole diamine sulfonic acid salt and step i) comprises i-a) dissolving the 4,5,6,7-tetrahydro-benzothiazole diamine sulfonic acid salt in a solvent selected from dichloromethane/water or water i-b)adding NaOH to increase the pH, i-c) isolating the 4,5,6,7-tetrahydro-benzothiazole diamine, and i-d) dissolving the 4,5,6,7-tetrahydro-benzothiazole diamine in a solvent.

25. The process of claim 20 , wherein steps a. and b. further comprise stirring.

26. The process of claim 20 wherein step c. comprises one or more steps selected from filtering the reaction mixture to isolate a precipitate, washing a precipitate, and drying a precipitate.

27. A process for preparing a chirally purified (6R)-4,5,6,7,-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride comprising:

a. heating a solution to a temperature of from about 65° C. to about 125° C., the solution comprising entantiomerically enriched (6R)2,6 diamino-4,5,6,7-tetrahydro-benzothiazole in an organic solvent; and

an n-propyl halide in a solvent to form a reaction mixture;

b. reacting the reaction mixture at a temperature of from about 65° C. to about 125° C.;

c. recovering a chirally purified substituted (6R)-4,5,6,7,-tetrahydro-N6-propyl-2,6-benzothiazole-diamine monohydrochloride salt, and

d. converting the chirally purified substituted (6R)-4,5,6,7,-tetrahydro-N6-propyl-2,6-benzothiazole-diamine monohydrochloride salt to the chirally purified (6R)-4,5,6,7,-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride.

28. The process of claim 23 , wherein the steps of heating in step a., and reacting in step b., are carried out from about 65° C. to about 100° C.

29. The process of claim 23 , wherein the steps of heating in step a., and reacting in step b., are carried out from about 65° C. to about 95° C.

30. The process of claim 23 , wherein the n-propyl halide is n-propyl chloride.

31. The process of claim 23 , wherein the solvent is selected from an organic solvent and an organic solvent mixed with water.

32. The process of claim 23 , wherein steps a., b., and each further comprise stirring.

33. The process of claim 23 , wherein step c. comprises one or more steps selected from filtering the reaction mixture to isolate a precipitate, washing a precipitate, and drying a precipitate.

34. The process of claim 23 , wherein step d comprises i) dissolving the (6R)-4,5,6,7,-tetrahydro-N6-propyl-2,6-benzothiazole-diamine or salt thereof of step c. in a solvent; ii) adding hydrochloric acid and iii) isolating the (6R)-4,5,6,7,-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride.

35. The process of claim 30 , wherein steps a. and b further comprise stirring.

36. The process of claim 30 wherein step c. comprises one or more steps selected from filtering the reaction mixture to isolate a precipitate, washing a precipitate, and drying a precipitate.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Nov 21, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: ARETEIA THERAPEUTICS, INC.
Reel/Frame 072993/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2025
From: KNOPP BIOSCIENCES LLC
To: ARETEIA THERAPEUTICS, INC.
Reel/Frame 073077/0717 →
SECURITY INTEREST Recorded Oct 10, 2025
From: ARETEIA THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 072540/0980 →
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2022
From: AMERICAN MONEY MANAGEMENT CORPORATION
To: KNOPP BIOSCIENCES LLC
Reel/Frame 059572/0530 →
SECURITY INTEREST Recorded Apr 12, 2021
From: KNOPP BIOSCIENCES LLC
To: AMERICAN MONEY MANAGEMENT CORPORATION
Reel/Frame 055889/0064 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: MCCALL, JOHN M.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043904/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: CHEN, JIAN-XIE
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043904/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: LAPINA, OLGA V.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043904/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: RAJE, PRASAD
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043903/0989 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: GADIKOTA, RAJENDRAKUMAR REDDY
To: KNOPP BIOSCIENCES LLC
Reel/Frame 043904/0124 →
Continuity (5)
Continuation 13973987 · Aug 22, 2013
Continuation 12049235 · Mar 14, 2008
Provisional Application 60894829 · Mar 14, 2007
Provisional Application 60894814 · Mar 14, 2007
Related Publication 20170158649A1 · Jun 8, 2017